Antiphospholipid antibodies: Do we still need to perform anticardiolipin ELISA assays?

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 7, 2004, Pages 1071-1073

  de Moerloose, Philippe ^a   Reber, G ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHATIDIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; THROMBOPLASTIN;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LABORATORY TEST; MEDICAL ASSESSMENT; MEDICAL SOCIETY; MORBIDITY; NON INVASIVE MEASUREMENT; NOTE; PARTIAL THROMBOPLASTIN TIME; PATIENT CODING; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; THROMBOEMBOLISM; THROMBOPLASTIN TIME; UNITED STATES;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; LUPUS COAGULATION INHIBITOR; PRACTICE GUIDELINES; SENSITIVITY AND SPECIFICITY;

EID: 13244295426     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00811.x     Document Type: Note

References (28)

1. Wilson WA, Gharavi AE, Koike T, Lockshin D, Branch DW, Piette J-C, Brey R, Derksen R, Harris EN, Hughes GRV, Tripplet DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42 1309-11.
2. Arnout J. ISTH Scientific Standardisation Subcommittee Lupus Anticoagulants/Phospholipid dependent antibodies. International Society of Thrombosis and Haemostasis, Boston, July 2002.
3. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factor of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2002; 101: 1827-32.
4. 2-glycoprotein I antibodies and thrombosis. Clin Rev Allergy Immunol 1995; 13: 67-72.
5. 2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
6. Ebeling F, Pettersson T, Muukkonen L, Vahtera E, Rasi V. Beta-2-glycoprotein I antibodies in patients with thrombosis. Scand J Clin Lab 2003; 63: 11-8.
7. Nash MJ, Camilleri RS, Kunka S, Mackie IJ, Machin S, Cohen H. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost 2004: 2: 1077-81.
8. Avcin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002; 11: 4-10.
9. Wenzel C, Stoiser B, Locker GJ, Laczika K, Quehenberger P, Kapiotis S, Frass M, Pabinger I, Knobl P. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions. Crit Care Med 2002; 30: 763-70.
10. Galli M, Finazzi G, Norbis F, Marziali S, Marchioli R, Barbui T. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile. Thromb Haemost 1999; 81: 695-700.
11. Regnault V, Beguin S, Wahl D, de Maistre E, Hemker HC, Lecompte T. Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Thromb Haemost 2003; 89: 208-12.
12. Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 2000; 15: 163-72.
13. Roussi J, Roisin J-P, Goguel A. Lupus anticoagulants. First French Interlaboratory Etalanorme Survey. Am J Clin Pathol 1996; 105: 788-93.
14. Jennings I, Greaves M, Mackie IJ, Woods TA, Preston E. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 2002; 119: 364-9.
15. Arnout J, Meijer P, Vermylen J. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against beta2-glycoprotein I. Thromb Haemost 1999; 81: 929-34.
16. Arnout J. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thromb Haemost 2001; 86: 83-91.
17. Lawrie AS, Mackie IJ, Purdy G, Machin SJ. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performances between photo-optical and mechanical coagulometers. Thromb Haemost 1999; 81: 758-62.
18. Roubey RAS. Antiphospholipid syndrome: antibodies and antigens. Curr Opin Hematol 2000; 7: 316-20.
19. 2-glycoprotein I measurement. A collaborative study. Thromb Haemost 2002; 88: 66-73.
20. Lee RM, Emlen W, Scott JR, Branch DW, Silver RM. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol 1999; 181: 642-8.
21. Hsieh K, Knöbl P, Rintelen C, Kyrle PA, Quehenberger P, Bialonczyk C, Partsch H, Lechner K, Pabinger I. Is the determination of anti-beta 2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? Br J Haematol 2003; 123: 490-5.
22. 2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717-23.
23. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-52.
24. Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G, Koike T, Ichikawa K, Meroni P, Boffa MC. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-83.
25. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibodies assays. A cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002; 118: 548-57.
26. Stone S, Langford K, Nelson-Piercy C, Khamashta MA, Bewley S, Hunt BJ. Antiphospholipid antibodies do not a syndrome make. Lapus 2002; 11: 130-3.
27. Hughes GR, Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis 2003; 62: 1127.
28. 2-glycoprotein 1 increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus. Q J Med 1998; 91: 125-30.